What Solutions Exist for Developmental Delays Facing Indigenous Children Globally? A Co-Designed Systematic Review.

Autor: Macniven R; School of Population Health, University of New South Wales, Sydney 2052, Australia.; Poche Centre for Indigenous Health, Faculty of Health and Medicine, The University of Sydney, Sydney 2006, Australia.; Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney 2109, Australia., Jeffries TL Jr; Poche Centre for Indigenous Health, Faculty of Health and Medicine, The University of Sydney, Sydney 2006, Australia., Meharg D; Poche Centre for Indigenous Health, Faculty of Health and Medicine, The University of Sydney, Sydney 2006, Australia., Talbot F; Poche Centre for Indigenous Health, Faculty of Health and Medicine, The University of Sydney, Sydney 2006, Australia., Rambaldini B; Poche Centre for Indigenous Health, Faculty of Health and Medicine, The University of Sydney, Sydney 2006, Australia., Edwards E; Toomelah Public School, Boggabilla 2409, Australia., Hickie IB; Brain and Mind Centre, The University of Sydney, Sydney 2006, Australia., Sloan M; Toomelah Public School, Boggabilla 2409, Australia., Gwynne K; Poche Centre for Indigenous Health, Faculty of Health and Medicine, The University of Sydney, Sydney 2006, Australia.; Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney 2109, Australia.

Publikováno v: Children (Basel, Switzerland) [Children (Basel)] 2020 Dec 10; Vol. 7 (12). Date of Electronic Publication: 2020 Dec 10.

Polyclonal HIV envelope-specific breast milk antibodies limit founder SHIV acquisition and cell-associated virus loads in infant rhesus monkeys.

Autor: Himes JE; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Goswami R; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Mangan RJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Kumar A; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Jeffries TL Jr; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Eudailey JA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Heimsath H; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Nguyen QN; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Pollara J; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., LaBranche C; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Chen M; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Vandergrift NA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Peacock JW; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Schiro F; Tulane National Primate Research Center, Tulane University, Covington, LA, USA., Midkiff C; Tulane National Primate Research Center, Tulane University, Covington, LA, USA., Ferrari G; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Montefiori DC; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Hernandez XA; Tulane National Primate Research Center, Tulane University, Covington, LA, USA., Aye PP; Tulane National Primate Research Center, Tulane University, Covington, LA, USA., Permar SR; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA. sallie.permar@duke.edu.; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, USA. sallie.permar@duke.edu.; Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA. sallie.permar@duke.edu.; Department of Immunology, Duke University School of Medicine, Durham, NC, USA. sallie.permar@duke.edu.

Publikováno v: Mucosal immunology [Mucosal Immunol] 2018 Nov; Vol. 11 (6), pp. 1716-1726. Date of Electronic Publication: 2018 Aug 16.

The function and affinity maturation of HIV-1 gp120-specific monoclonal antibodies derived from colostral B cells.

Autor: Jeffries TL Jr; Duke University Medical Center, Duke Human Vaccine Institute, Durham, North Carolina, USA., Sacha CR; Duke University Medical Center, Duke Human Vaccine Institute, Durham, North Carolina, USA., Pollara J; Duke University Medical Center, Duke Human Vaccine Institute, Durham, North Carolina, USA., Himes J; Duke University Medical Center, Duke Human Vaccine Institute, Durham, North Carolina, USA., Jaeger FH; Duke University Medical Center, Duke Human Vaccine Institute, Durham, North Carolina, USA., Dennison SM; Duke University Medical Center, Duke Human Vaccine Institute, Durham, North Carolina, USA., McGuire E; Duke University Medical Center, Duke Human Vaccine Institute, Durham, North Carolina, USA., Kunz E; Duke University Medical Center, Duke Human Vaccine Institute, Durham, North Carolina, USA., Eudailey JA; Duke University Medical Center, Duke Human Vaccine Institute, Durham, North Carolina, USA., Trama AM; Duke University Medical Center, Duke Human Vaccine Institute, Durham, North Carolina, USA., LaBranche C; Duke University Medical Center, Duke Human Vaccine Institute, Durham, North Carolina, USA., Fouda GG; Duke University Medical Center, Duke Human Vaccine Institute, Durham, North Carolina, USA., Wiehe K; Duke University Medical Center, Duke Human Vaccine Institute, Durham, North Carolina, USA., Montefiori DC; Duke University Medical Center, Duke Human Vaccine Institute, Durham, North Carolina, USA., Haynes BF; Duke University Medical Center, Duke Human Vaccine Institute, Durham, North Carolina, USA., Liao HX; Duke University Medical Center, Duke Human Vaccine Institute, Durham, North Carolina, USA., Ferrari G; Department of Surgery, Duke University, Durham, North Carolina, USA., Alam SM; Duke University Medical Center, Duke Human Vaccine Institute, Durham, North Carolina, USA., Moody MA; Duke University Medical Center, Duke Human Vaccine Institute, Durham, North Carolina, USA., Permar SR; Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA.

Publikováno v: Mucosal immunology [Mucosal Immunol] 2016 Mar; Vol. 9 (2), pp. 414-27. Date of Electronic Publication: 2015 Aug 05.

HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria.

Autor: Trama AM; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Immunology, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA. Electronic address: ashley.trama@dm.duke.edu., Moody MA; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Pediatrics, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA., Alam SM; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA., Jaeger FH; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA., Lockwood B; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA., Parks R; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA., Lloyd KE; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA., Stolarchuk C; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA., Scearce R; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA., Foulger A; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA., Marshall DJ; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA., Whitesides JF; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA., Jeffries TL Jr; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA., Wiehe K; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA., Morris L; Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg 2131, South Africa., Lambson B; Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg 2131, South Africa., Soderberg K; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA., Hwang KK; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA., Tomaras GD; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Surgery, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Molecular Genetics and Microbiology, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA., Vandergrift N; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA., Jackson KJL; Department of Pathology, Stanford University, Palo Alto, CA 94305, USA., Roskin KM; Department of Pathology, Stanford University, Palo Alto, CA 94305, USA., Boyd SD; Department of Pathology, Stanford University, Palo Alto, CA 94305, USA., Kepler TB; Department of Microbiology, Boston University, Boston, MA 02215, USA., Liao HX; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA., Haynes BF; Duke Human Vaccine Institute, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Immunology, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine and Duke Global Health Institute, Durham, NC 27710, USA. Electronic address: barton.haynes@dm.duke.edu.

Publikováno v: Cell host & microbe [Cell Host Microbe] 2014 Aug 13; Vol. 16 (2), pp. 215-226.